Importer of Controlled Substances Application: Nostrum Laboratories, Inc., 36946 [2019-16173]

Download as PDF 36946 Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.34(a), this is notice that on May 31, 2019, Catalent Pharma Solutions, LLC, 3031 Red Lion Road, Philadelphia, Pennsylvania 19114 applied to be registered as an importer of the following basic class of controlled substance: SUPPLEMENTARY INFORMATION: Controlled substance Gamma Hydroxybutyric Acid. Drug code Schedule 2010 I The company plans to import finished dosage unit products containing gamma- hydroxybutyric acid for clinical trials, research, and analytical activities. Dated: July 16, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–16166 Filed 7–29–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Xcelience ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 29, 2019. Such persons may also file a written request for a hearing on the application on or before August 29, 2019. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on May 2, 2019, Xcelience, 4901 West Grace Street, Tampa, Florida 33607, applied to be registered as an importer of the following basic class of controlled substance: Controlled substance Drug code Amphetamine ......................................................................................................................................................... The company plans to import the listed controlled substance in finished dosage form for clinical trials, research and analytical purposes. Dated: July 16, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–16168 Filed 7–29–19; 8:45 am] BILLING CODE 4410–09–P Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 29, 2019. Such persons may also file a written request for a hearing on the application on or before August 29, 2019. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: ADDRESSES: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Nostrum Laboratories, Inc. ACTION: Notice of application. 1100 SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on March 13, 2019, Nostrum Laboratories, Inc., 705 East Mulberry Street, Bryan, Ohio 43506 applied to be registered as an importer of the following basic class of controlled substance: Drug code jspears on DSK3GMQ082PROD with NOTICES Marihuana Extract .................................................................................................................................................. Marihuana .............................................................................................................................................................. VerDate Sep<11>2014 16:42 Jul 29, 2019 Jkt 247001 consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. PO 00000 Frm 00063 Fmt 4703 II Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. Controlled substance The company plans to import the listed controlled substances for research and new drug development. Approval of permit applications will occur only when the registrant’s business activity is Schedule Sfmt 9990 7350 7360 Schedule I I Dated: July 16, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–16173 Filed 7–29–19; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\30JYN1.SGM 30JYN1

Agencies

[Federal Register Volume 84, Number 146 (Tuesday, July 30, 2019)]
[Notices]
[Page 36946]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16173]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Nostrum 
Laboratories, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before August 29, 2019. 
Such persons may also file a written request for a hearing on the 
application on or before August 29, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: 
    In accordance with 21 CFR 1301.34(a), this is notice that on March 
13, 2019, Nostrum Laboratories, Inc., 705 East Mulberry Street, Bryan, 
Ohio 43506 applied to be registered as an importer of the following 
basic class of controlled substance:

------------------------------------------------------------------------
       Controlled substance             Drug code           Schedule
------------------------------------------------------------------------
Marihuana Extract................                7350  I
Marihuana........................                7360  I
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
research and new drug development. Approval of permit applications will 
occur only when the registrant's business activity is consistent with 
what is authorized under 21 U.S.C. 952(a)(2). Authorization will not 
extend to the import of FDA approved or non-approved finished dosage 
forms for commercial sale.

    Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-16173 Filed 7-29-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.